Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Biorem Inc (BRM) Stock Price & Analysis

20 Followers

BRM Stock Chart & Stats

CA$4.44CA$0.69(18.40%)
At close: 4:00 PM EST
C$3.5C$4Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
CAD 3.93 - CAD 4.44
52-Week Range
CAD 2.04 - CAD 4.44
Previous Close
CAD 3.75
Volume
N/A
Average Volume (3M)
16.15K
Market Cap
CAD 61.15M
Enterprise Value
CAD 55.84M
Total Cash (Recent Filing)
CAD 7.19M
Total Debt (Recent Filing)
CAD 2.49M
Price to Earnings (P/E)
11.5
Beta
0.40
Next Earnings
Mar 30, 2027 (Est.)
EPS Estimate
0.1
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Improving revenue scale indicates that Biorem is expanding its commercial activity and converting demand into higher sales. Continued growth provides operating leverage, supports reinvestment in engineered systems and services, and strengthens the company’s ability to sustain profitability over the next several quarters.

Profitability

Healthy operating, EBITDA, and net margins show that Biorem retains meaningful profitability while growing. This cost-control profile can help the company fund operations internally, absorb project variability, and preserve earnings power if revenue growth moderates during the next two to six months.

Low Leverage

The substantial reduction in leverage has improved Biorem’s financial flexibility and reduced balance-sheet strain. Lower debt exposure leaves more capacity to support project execution, invest in growth, and withstand weaker periods without the same refinancing or interest burden associated with earlier leverage levels.

Bears Say

Weak Cash Conversion

The sharp gap between reported earnings and recent cash generation indicates weaker cash conversion and increases sensitivity to working-capital movements or cash investment needs. Until operating cash flow recovers, Biorem has less internally generated liquidity to fund growth and absorb execution variability.

Revenue Variability

The earlier revenue decline and only moderately stable gross margins show that Biorem’s results can vary with demand and project mix. Such variability may make future earnings less predictable and could limit the consistency of operating leverage even as the longer-term revenue trend improves.

Earnings Sustainability

Very high returns on equity are attractive but may not be fully repeatable if earnings weaken or normalize. A decline in profitability would reduce the efficiency signal and could make current earnings quality appear less durable, particularly alongside the recent deterioration in cash conversion.

Biorem Inc News

BRM FAQ

What was Biorem Inc’s price range in the past 12 months?
Biorem Inc lowest stock price was C$2.04 and its highest was C$4.44 in the past 12 months.
What is Biorem Inc’s market cap?
Biorem Inc’s market cap is C$61.15M.
When is Biorem Inc’s upcoming earnings report date?
Biorem Inc’s next earnings report is estimated for Mar 30, 2027 (not yet confirmed), which is in 145 days.
How were Biorem Inc’s earnings last quarter?
Biorem Inc released its earnings results on Nov 04, 2026. The company reported C$0.148 earnings per share for the quarter, beating the consensus estimate of C$0.094 by C$0.054.
Is Biorem Inc overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Biorem Inc pay dividends?
Biorem Inc does not currently pay dividends.
What is Biorem Inc’s EPS estimate?
Biorem Inc’s EPS estimate is 0.10.
How many shares outstanding does Biorem Inc have?
Biorem Inc has 16,307,028 shares outstanding.
What happened to Biorem Inc’s price movement after its last earnings report?
Biorem Inc reported an EPS of C$0.148 in its last earnings report, beating expectations of C$0.094. Following the earnings report the stock price went up 18.4%.
Which hedge fund is a major shareholder of Biorem Inc?
Currently, no hedge funds are holding shares in TSE:BRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology